Hebei Lansheng Biotech Co., Ltd.
ShangHai Yuelian Biotech Co., Ltd.

Construction begins on Inner Mongolia New Veyong’s annual 500-ton emamectin benzoate projectqrcode

Apr. 21, 2020

Favorites Print
Apr. 21, 2020
On April 2, Inner Mongolia New Veyong Biochemical held a commencement ceremony to signal the start of the construction of its 500-ton emamectin benzoate project in China.
Inner Mongolia New Veyong is committed to the innovation of biotechnology and protection of the environment through the creation of green products and provision of eco-agricultural services, backed by the emamectin benzoate product, which will become a featured product of the company. The emamectin benzoate product is a newly synthetic product added to the product range of the company, which is an important reflection of the company's product line expansion and enhancement of its differentiated competitive edge, showing that the business of the company is moving from single biological fermentation to chemical synthesis. 
The project office is responsible for the civil works of the Inner Mongolia New Veyong project—an annual 500-ton emamectin benzoate production facility. The project office is prepared to dedicatedly undertake the construction activities with full devotion to ensure the project quality and work safety. With this effort, the project office will be able to complete the construction of the project on schedule, which is a contribution to the circular economic development and ecological protection.
Source: AgroNews

Picture 0/1200

More from AgroNews

I wanna post a press Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.